3T MRI at Belfair Integrates CorTechs Labs’ Latest Software to Support Improved Prostate Cancer Detection

BLUFFTON, S.C. & SAN DIEGO – November 11, 2020 – ( Newswire.com )

3T MRI at Belfair has officially implemented CorTechs Labs’ OnQ ProstateTM to advance its radiology interpretations of prostate cancer imaging. 

3T MRI at Belfair was one of the first imaging centers on North America’s east coast to implement NeuroQuant®, CorTechs Labs’ flagship software for advanced volumetric imaging. Today, the imaging center announced its integration of the latest CorTechs Labs product, OnQ Prostate, to support improved detection of clinically significant prostate cancer, made possible through the software’s integration of an advanced diffusion MRI technique known as restriction spectrum imaging (RSI).

“The addition of OnQ Prostate to our AI-software portfolio is critical to our ability to continue providing the most advanced, cutting-edge technology to our community,” said A. Joseph Borelli Jr., M.D., president and medical director of 3T MRI at Belfair.

OnQ Prostate is FDA-cleared post-processing software

Read More